US Stock MarketDetailed Quotes

Centessa Pharmaceuticals (CNTA)

Watchlist
  • 39.580
  • -0.030-0.08%
Close May 13 16:00 ET
  • 39.580
  • 0.0000.00%
Post 17:37 ET
6.12BMarket Cap-22.24P/E (TTM)

Centessa Pharmaceuticals (CNTA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-26.16%-72.22M
-36.44%-193.82M
-30.39%-55.81M
-172.63%-58.31M
44.67%-22.45M
-53.53%-57.25M
11.40%-142.06M
-37.84%-42.8M
42.80%-21.39M
7.90%-40.58M
Net income from continuing operations
-203.20%-79.24M
16.21%-197.53M
40.57%-66.16M
-28.96%-54.89M
-14.90%-50.34M
31.31%-26.14M
-56.04%-235.76M
-202.22%-111.33M
-10.14%-42.57M
-76.07%-43.82M
Operating gains losses
----
----
----
----
----
----
--34.1M
----
----
----
Depreciation and amortization
10.14%239K
-2.23%921K
4.78%241K
0.42%237K
-4.24%226K
-9.58%217K
16.30%942K
-6.50%230K
-0.84%236K
-0.42%236K
Deferred tax
-16.78%828K
-5.43%2.51M
-41.46%233K
-79.67%255K
80.95%1.03M
129.26%995K
110.00%2.65M
367.11%398K
143.39%1.25M
102.41%567K
Other non cash items
-15.18%352K
1,750.00%1.15M
261.31%271K
--271K
--190K
--415K
121.43%62K
-150.75%-168K
----
----
Change In working capital
85.01%-5.78M
-235.83%-30.02M
-95.15%1.23M
-195.43%-11.26M
415.63%18.55M
-320.36%-38.54M
217.20%22.1M
851.38%25.34M
365.50%11.8M
-21.55%-5.88M
-Change in receivables
15.62%-3.61M
-9.94%-7.26M
69.23%-3.72M
-201.42%-9.98M
293.07%10.73M
-454.26%-4.28M
45.41%-6.6M
-52.43%-12.1M
523.90%9.84M
9.49%-5.56M
-Change in prepaid assets
232.10%3.54M
-176.84%-7.85M
-232.37%-5.94M
-198.08%-3.94M
414.66%4.7M
-183.31%-2.68M
849.19%10.22M
143.04%4.49M
261.77%4.01M
17.23%-1.49M
-Change in payables and accrued expense
81.82%-5.75M
-183.39%-15.17M
-67.06%10.83M
221.93%2.59M
178.25%3.06M
-131.58%-31.65M
616.79%18.19M
1,150.08%32.88M
-1,023.91%-2.13M
-78.88%1.1M
-Change in other current assets
-18.46%53K
-15.10%253K
-15.07%62K
-14.86%63K
-16.00%63K
-14.47%65K
115.83%298K
-14.12%73K
-41.27%74K
103.58%75K
Cash from discontinued investing activities
Operating cash flow
-26.16%-72.22M
-36.44%-193.82M
-30.39%-55.81M
-172.63%-58.31M
44.67%-22.45M
-53.53%-57.25M
11.40%-142.06M
-37.84%-42.8M
42.80%-21.39M
7.90%-40.58M
Investing cash flow
Cash flow from continuing investing activities
119.20%42.71M
-1,438.57%-418.53M
-972.54%-218.13M
37.77%61.95M
27.96%-39.95M
-1,426.74%-222.39M
124.62%31.27M
236.80%25M
-7.68%44.96M
22.00%-55.46M
Net PPE purchase and sale
----
-991.18%-371K
---11K
-588.24%-234K
----
----
79.88%-34K
--0
20.93%-34K
--0
Net investment purchase and sale
119.20%42.71M
-1,435.93%-418.16M
-972.49%-218.12M
38.18%62.18M
28.18%-39.83M
-1,426.74%-222.39M
124.68%31.3M
237.01%25M
-7.69%45M
21.99%-55.46M
Cash from discontinued investing activities
Investing cash flow
119.20%42.71M
-1,438.57%-418.53M
-972.54%-218.13M
37.77%61.95M
27.96%-39.95M
-1,426.74%-222.39M
124.62%31.27M
236.80%25M
-7.68%44.96M
22.00%-55.46M
Financing cash flow
Cash flow from continuing financing activities
887.27%30.47M
-20.08%291.53M
9,464.63%283.4M
-98.60%3.44M
-98.48%1.61M
-70.59%3.09M
1,627.29%364.75M
-53.42%2.96M
1,568.36%245.98M
877,508.33%105.31M
Net issuance payments of debt
----
--0
----
----
----
----
---762K
----
----
----
Net common stock issuance
--0
-23.43%275.36M
897,596.67%269.25M
--0
--0
-36.73%6.11M
1,628.29%359.61M
-100.48%-30K
1,566.49%242.71M
--107.27M
Proceeds from stock option exercised by employees
1,835.39%34.12M
90.27%21.36M
168.29%14.33M
-16.09%3.56M
112.59%1.71M
110.38%1.76M
3,521.61%11.23M
4,427.12%5.34M
2,258.33%4.25M
6,583.33%802K
Net other financing activities
23.65%-3.65M
2.37%-5.19M
88.59%-181K
87.11%-125K
---100K
---4.79M
---5.32M
---1.59M
---970K
----
Cash from discontinued financing activities
Financing cash flow
887.27%30.47M
-20.08%291.53M
9,464.63%283.4M
-98.60%3.44M
-98.48%1.61M
-70.59%3.09M
1,627.29%364.75M
-53.42%2.96M
1,568.36%245.98M
877,508.33%105.31M
Net cash flow
Beginning cash position
-83.83%61.95M
199.32%383.22M
-87.14%50.81M
-65.27%44.24M
-11.05%105.16M
199.32%383.22M
-67.48%128.03M
130.34%395.03M
-12.29%127.37M
-54.53%118.22M
Current changes in cash
100.34%950K
-226.32%-320.82M
163.75%9.46M
-97.38%7.07M
-755.61%-60.8M
-2,656.93%-276.55M
195.39%253.96M
65.47%-14.84M
934.45%269.56M
108.05%9.27M
Effect of exchange rate changes
112.00%182K
-136.51%-448K
-44.49%1.68M
73.69%-501K
5.83%-113K
-792.69%-1.52M
99.51%1.23M
701.59%3.03M
-965.45%-1.9M
-131.50%-120K
End cash Position
-40.01%63.09M
-83.83%61.95M
-83.83%61.95M
-87.14%50.81M
-65.27%44.24M
-11.05%105.16M
199.32%383.22M
199.32%383.22M
130.34%395.03M
-12.29%127.37M
Free cash flow
-26.16%-72.22M
-36.67%-194.19M
-30.42%-55.82M
-173.29%-58.55M
44.36%-22.58M
-53.53%-57.25M
11.48%-142.09M
-37.72%-42.8M
42.77%-21.42M
7.92%-40.58M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -26.16%-72.22M-36.44%-193.82M-30.39%-55.81M-172.63%-58.31M44.67%-22.45M-53.53%-57.25M11.40%-142.06M-37.84%-42.8M42.80%-21.39M7.90%-40.58M
Net income from continuing operations -203.20%-79.24M16.21%-197.53M40.57%-66.16M-28.96%-54.89M-14.90%-50.34M31.31%-26.14M-56.04%-235.76M-202.22%-111.33M-10.14%-42.57M-76.07%-43.82M
Operating gains losses --------------------------34.1M------------
Depreciation and amortization 10.14%239K-2.23%921K4.78%241K0.42%237K-4.24%226K-9.58%217K16.30%942K-6.50%230K-0.84%236K-0.42%236K
Deferred tax -16.78%828K-5.43%2.51M-41.46%233K-79.67%255K80.95%1.03M129.26%995K110.00%2.65M367.11%398K143.39%1.25M102.41%567K
Other non cash items -15.18%352K1,750.00%1.15M261.31%271K--271K--190K--415K121.43%62K-150.75%-168K--------
Change In working capital 85.01%-5.78M-235.83%-30.02M-95.15%1.23M-195.43%-11.26M415.63%18.55M-320.36%-38.54M217.20%22.1M851.38%25.34M365.50%11.8M-21.55%-5.88M
-Change in receivables 15.62%-3.61M-9.94%-7.26M69.23%-3.72M-201.42%-9.98M293.07%10.73M-454.26%-4.28M45.41%-6.6M-52.43%-12.1M523.90%9.84M9.49%-5.56M
-Change in prepaid assets 232.10%3.54M-176.84%-7.85M-232.37%-5.94M-198.08%-3.94M414.66%4.7M-183.31%-2.68M849.19%10.22M143.04%4.49M261.77%4.01M17.23%-1.49M
-Change in payables and accrued expense 81.82%-5.75M-183.39%-15.17M-67.06%10.83M221.93%2.59M178.25%3.06M-131.58%-31.65M616.79%18.19M1,150.08%32.88M-1,023.91%-2.13M-78.88%1.1M
-Change in other current assets -18.46%53K-15.10%253K-15.07%62K-14.86%63K-16.00%63K-14.47%65K115.83%298K-14.12%73K-41.27%74K103.58%75K
Cash from discontinued investing activities
Operating cash flow -26.16%-72.22M-36.44%-193.82M-30.39%-55.81M-172.63%-58.31M44.67%-22.45M-53.53%-57.25M11.40%-142.06M-37.84%-42.8M42.80%-21.39M7.90%-40.58M
Investing cash flow
Cash flow from continuing investing activities 119.20%42.71M-1,438.57%-418.53M-972.54%-218.13M37.77%61.95M27.96%-39.95M-1,426.74%-222.39M124.62%31.27M236.80%25M-7.68%44.96M22.00%-55.46M
Net PPE purchase and sale -----991.18%-371K---11K-588.24%-234K--------79.88%-34K--020.93%-34K--0
Net investment purchase and sale 119.20%42.71M-1,435.93%-418.16M-972.49%-218.12M38.18%62.18M28.18%-39.83M-1,426.74%-222.39M124.68%31.3M237.01%25M-7.69%45M21.99%-55.46M
Cash from discontinued investing activities
Investing cash flow 119.20%42.71M-1,438.57%-418.53M-972.54%-218.13M37.77%61.95M27.96%-39.95M-1,426.74%-222.39M124.62%31.27M236.80%25M-7.68%44.96M22.00%-55.46M
Financing cash flow
Cash flow from continuing financing activities 887.27%30.47M-20.08%291.53M9,464.63%283.4M-98.60%3.44M-98.48%1.61M-70.59%3.09M1,627.29%364.75M-53.42%2.96M1,568.36%245.98M877,508.33%105.31M
Net issuance payments of debt ------0-------------------762K------------
Net common stock issuance --0-23.43%275.36M897,596.67%269.25M--0--0-36.73%6.11M1,628.29%359.61M-100.48%-30K1,566.49%242.71M--107.27M
Proceeds from stock option exercised by employees 1,835.39%34.12M90.27%21.36M168.29%14.33M-16.09%3.56M112.59%1.71M110.38%1.76M3,521.61%11.23M4,427.12%5.34M2,258.33%4.25M6,583.33%802K
Net other financing activities 23.65%-3.65M2.37%-5.19M88.59%-181K87.11%-125K---100K---4.79M---5.32M---1.59M---970K----
Cash from discontinued financing activities
Financing cash flow 887.27%30.47M-20.08%291.53M9,464.63%283.4M-98.60%3.44M-98.48%1.61M-70.59%3.09M1,627.29%364.75M-53.42%2.96M1,568.36%245.98M877,508.33%105.31M
Net cash flow
Beginning cash position -83.83%61.95M199.32%383.22M-87.14%50.81M-65.27%44.24M-11.05%105.16M199.32%383.22M-67.48%128.03M130.34%395.03M-12.29%127.37M-54.53%118.22M
Current changes in cash 100.34%950K-226.32%-320.82M163.75%9.46M-97.38%7.07M-755.61%-60.8M-2,656.93%-276.55M195.39%253.96M65.47%-14.84M934.45%269.56M108.05%9.27M
Effect of exchange rate changes 112.00%182K-136.51%-448K-44.49%1.68M73.69%-501K5.83%-113K-792.69%-1.52M99.51%1.23M701.59%3.03M-965.45%-1.9M-131.50%-120K
End cash Position -40.01%63.09M-83.83%61.95M-83.83%61.95M-87.14%50.81M-65.27%44.24M-11.05%105.16M199.32%383.22M199.32%383.22M130.34%395.03M-12.29%127.37M
Free cash flow -26.16%-72.22M-36.67%-194.19M-30.42%-55.82M-173.29%-58.55M44.36%-22.58M-53.53%-57.25M11.48%-142.09M-37.72%-42.8M42.77%-21.42M7.92%-40.58M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More